Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr;45(4):e16167.
doi: 10.1111/liv.16167. Epub 2024 Nov 15.

Novel Emerging Mechanisms in Acetaminophen (APAP) Hepatotoxicity

Affiliations
Review

Novel Emerging Mechanisms in Acetaminophen (APAP) Hepatotoxicity

Alejandro Hionides-Gutierrez et al. Liver Int. 2025 Apr.

Abstract

Background: Drug-induced liver injury represents a critical public health issue, marked by unpredictable and potentially severe adverse reactions to medications, herbal products or dietary supplements.

Aims: Acetaminophen is notably a leading cause of hepatotoxicity, impacting over one million individuals worldwide.

Materials & methods: Extensive research has elucidated the intricate mechanisms driving APAP-induced liver injury, emphasising the significant roles of endoplasmic reticulum stress, oxidative stress, mitochondrial dysfunction and cell death.

Results: These insights pave the way for innovative therapeutic strategies, including the use of magnesium, bile acids, microbiota modulation and mesenchymal stem cells.

Discussion & conclusion: This review explores into these pathological mechanisms, proposing viable therapeutic interventions for patients suffering from APAP-induced liver injury.

Keywords: APAP‐induced liver injury; biliary acids; cell death; endoplasmic reticulum; magnesium transporters; microbiota; mitochondrial dysfunction; oxidative stress.

PubMed Disclaimer

Similar articles

Cited by

References

    1. M. R. McGill and H. Jaeschke, “Biomarkers of Drug‐Induced Liver Injury: Progress and Utility in Research, Medicine, and Regulation,” Expert Review of Molecular Diagnostics 18, no. 9 (2018): 797–807.
    1. R. T. Stravitz and W. M. Lee, “Acute Liver Failure,” Lancet 394, no. 10201 (2019): 869–881.
    1. M. I. Lucena, M. Villanueva‐Paz, I. Alvarez‐Alvarez, et al., “Roadmap to DILI Research in Europe. A Proposal From COST Action ProEuroDILINet,” Pharmacological Research 200 (2024): 107046.
    1. H. J. Zimmerman, “Drug‐Induced Liver Disease,” Clinics in Liver Disease 4, no. 1 (2000): 73–96.
    1. X. Li, J. Ni, and L. Chen, “Advances in the Study of Acetaminophen‐Induced Liver Injury,” Frontiers in Pharmacology 14 (2023): 1239395.

MeSH terms

LinkOut - more resources